BETA Technologies acquired Biocogniv, developer of an agentic AI platform.
“During the three months ended June 30, 2026, the Company acquired Biocogniv, Inc. (“Biocogniv”), a developer of an agentic artificial intelligence (“AI”) platform, to assist in accelerating the design of software development in support of aircraft certification efforts. The total consideration consisted of Class A common stock valued at $ 10,797 , net cash of $ 2,561 , and a cash holdback of $ 1,645 for indemnification claims, payable in installments on the six - and twelve-month anniversaries of the closing date. The transaction was accounted for as an acquisition of assets because substantially all the fair value of the gross assets acquired were concentrated in a single identifiable asset. The Company recognized acquired in-process research and development (“IPR&D”) expense of $ 15,003 , as the AI platform did not have alternative future use at the time of the acquisition. The Company incurred direct transaction costs of $ 1,144 , which were recorded as research and development expense.”